Aventa Genomics rolls out Aventa FusionPlus test for cancer patients
Aventa FusionPlus is a next-generation sequencing test designed to identify translocations, gene fusions, and rearrangements across 361 genes…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Aventa FusionPlus is a next-generation sequencing test designed to identify translocations, gene fusions, and rearrangements across 361 genes…
The Dutch company will use the funds to complete the development of MUSA-3, advance it to the clinical…
Phillips-Medisize will leverage its global footprint, supply chain network and assembly automation capabilities to produce the devices and…
The CDx IVD kit will be designed to identify adult cancer patients with MSI-H solid tumours who may…
Both the therapeutic drug monitoring tests are intended to monitor biologic drugs Humira, Remicade, and their biosimilars at…
Under the agreement, Varex will supply X-ray tubes for the Nanox.ARC system and produce and supply the X-ray…
ZEISS and Boehringer Ingelheim will leverage their expertise in ophthalmological technology, data analytics, algorithms, and treatments to develop…
Empaveli Injector is a compact, single-use, on-body device designed to enable the subcutaneous self-administration of Empaveli (pegcetacoplan), a…
Developed in partnership with Mayo Clinic, ECG-AI LEF is an artificial intelligence-driven software-as-a-medical device to screen LEF using…
Based in Switzerland, MedAlliance has developed a sirolimus drug-eluting balloon platform technology called SELUTION SLR